Galectin Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $443k | 106k | 4.16 |
| 2025-03-31 | $12k | 9.3k | 1.29 |
| 2024-12-31 | $71k | 55k | 1.30 |
| 2024-09-30 | $79k | 29k | 2.76 |
| 2024-06-30 | $15k | 7.0k | 2.15 |
| 2021-09-30 | $9.0k | 2.4k | 3.74 |
| 2021-06-30 | $21k | 6.6k | 3.18 |
| 2021-03-31 | $68k | 31k | 2.19 |
| 2020-12-31 | $27k | 12k | 2.25 |
| 2020-09-30 | $46k | 17k | 2.66 |
| 2020-06-30 | $64k | 21k | 3.05 |
| 2020-03-31 | $27k | 13k | 2.02 |
| 2019-12-31 | $115k | 40k | 2.87 |
| 2019-09-30 | $72k | 20k | 3.62 |
| 2019-06-30 | $86k | 21k | 4.14 |
| 2019-03-31 | $677k | 132k | 5.11 |
| 2018-12-31 | $599k | 175k | 3.43 |
| 2018-09-30 | $37k | 6.2k | 5.96 |
| 2018-06-30 | $20k | 3.2k | 6.26 |
| 2018-03-31 | $96k | 20k | 4.75 |
| 2015-03-31 | $1.8k | 574 | 3.08 |
| 2014-12-31 | $4.0k | 1.4k | 2.83 |
| 2014-09-30 | $1.0k | 187 | 5.35 |
| 2014-06-30 | $5.0k | 395 | 12.66 |
| 2014-03-31 | $999 | 69 | 14.49 |
| 2013-12-31 | $26k | 3.3k | 7.88 |
| 2013-09-30 | $5.0k | 500 | 10.00 |